SRPT
Sarepta Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$20.11
−2.71%Forward multiples
Based on analyst estimates
- P/E forward
- 34.98x
- P/E 2026E
- 6.05x
- P/E 2027E
- 25.73x
- P/E 2028E
- 44.59x
- P/S forward
- 1.50x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.39x
- Price / sales
- 1.08x
- Price / cash flow
- -23.17x
Enterprise value
- Enterprise value
- $2.4B
- EV / sales
- 1.21x
- EV / EBITDA
- -163.30x
- EV / EBIT
- -16.63x
- Market cap
- $2.1B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026